Molecular docking analysis of sphingosine kinase 1 inhibitors for cancer management

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Sphingosine kinase 1 (SK1) is crucial for cell survival and proliferation.
• Overexpression of SK1 is linked to tumor progression in various cancers, making it a therapeutic target.
• Identifying novel SK1 inhibitors is essential for developing new anticancer therapies.

Purpose of the Study:

• To identify potential inhibitors of sphingosine kinase 1 (SK1) through virtual screening of natural compounds.
• To evaluate the binding affinity and specificity of identified compounds against SK1.
• To assess the drug-like properties of potential SK1 inhibitors for further experimental validation.

Main Methods:

• Virtual screening of 1068 natural compounds against the SK1 binding pocket.
• Selection of top hit compounds based on binding affinity and specificity.
• Evaluation of drug-like criteria for selected compounds.

Main Results:

• Four natural compounds (CNP0296172, CNP0368143, CNP0380570, CNP0290815) were identified as top hits.
• These compounds demonstrated strong binding affinity and specificity for the SK1 binding pocket.
• The identified compounds exhibited higher affinity than the positive control (PF-543) and met drug-like criteria.

Conclusions:

• The identified natural compounds are promising candidates for SK1 inhibition.
• These compounds warrant further experimental validation as potential anticancer agents.
• The study highlights the utility of virtual screening in discovering novel therapeutic leads for cancer.